Methylprednisolone Acetate Injectable Suspension Recalled for Failed Dissolution
Eugia US LLC recalls methylprednisolone acetate injection due to failed dissolution specifications. Affected states: Ohio, Tennessee, Louisiana, and Mississippi.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a FDA Class II recall with no reported illnesses or injuries. The hazard is a manufacturing quality defect affecting drug dissolution specifications, primarily an efficacy concern rather than an immediate safety threat.
Plain-English summary
Eugia US LLC is recalling methylprednisolone acetate injectable suspension, USP 400mg per 5mL vials due to failed dissolution specifications. The recalled product is a prescription steroid injection used for intra-articular, intralesional, intramuscular, or soft tissue injection.
The affected lots are 3MA23001, 3MA23002, and 3MA23003, with expiration date of 3/31/2025. Approximately 10,080 vials were distributed to Ohio, Tennessee, Louisiana, and Mississippi.
Consumers and healthcare providers should discontinue use of affected lots and contact Eugia US LLC or their healthcare provider for guidance on replacement product.
The recalled product
- Product
- METHYLPREDNISOLONE ACETATE (METHYLPREDNISOLONE ACETATE)
- Brand
- METHYLPREDNISOLONE ACETATE
- Manufacturer
- Eugia US LLC
- Category
- Drug — Injectable Steroid
- Hazard
- dissolution-defect
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 3MA23001
- 3MA23002
- 3MA23003
- Exp 3/31/2025
UPCs (2)
- 0355150313013
- 0355150314010
Distribution
Distributed in 4 states:
- LA
- MS
- OH
- TN
Related recalls
Same brand · METHYLPREDNISOLONE ACETATE
- HighPrescription Corticosteroid Injectable Recalled for Particulate Matter
FDA (Drugs) · 2024-05-22
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27